Allotex Announces New Investor and Expansion of Production Facilities
Allotex Inc. and SpA, a leading biologics and device company specializing in vision correction therapies, is pleased to announce that Junson Capital has joined its investor syndicate. This additional capital will help support the expansion of the Company’s production facility in preparation for market introduction and US clinical trials. Allotex’s innovative approach uses laser-shaped human […]
